Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist

References

• Strappe PM, Hampton DW, Cachon-Gonzalez B, et al. Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system. Eur J Pharm Biopharm 2005;61:126–33
   PubMed Web of Science ®Google Scholar
• Jain N, Aswal P, Goyal P, Bahadur P. Micellar structure of an ethylene oxide-propylene oxide block co-polymer. A small angle neutron scattering study. J Phys Chem 1998;102:8452–60
   Web of Science ®Google Scholar
• Stratton LP, Dong A, Manning M, Carpenter JF. Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. J Pharm Sci. 1997;86:1006–10
   PubMed Web of Science ®Google Scholar
• Morishita M, Barichello JM, Takayama K, et al. Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int J Pharm 2001;212:289–93
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Li N, et al. Sustained delivery of IL-1Ra from Pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res 2012;29:3475–85
   PubMed Web of Science ®Google Scholar
• Wang PL, Johnston TP. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407. J Parenter Sci Technol 1993;47:183–9
   PubMedGoogle Scholar
• Das N, Madan P, Lin S. Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin. Pharm Dev Technol 2012;17:363–74
   PubMed Web of Science ®Google Scholar
• Bresnihan B. Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist. Ann Rheum Dis 1999;58:196–8
   PubMed Web of Science ®Google Scholar
• Dayer JM, Feige U, Edwards CK, Burger D. Anti-interleukin-1 therapy in rheumatic diseases. Curr Opin Rheumatol 2001;13:170–6
   Google Scholar
• Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1 receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517–26
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Sun H, Chen S. Sustained delivery of IL-1Ra from PF127 gel reduces hyperglycemia in diabetic GK rats. PLoS One 2013;8:e55925
   Google Scholar
• Ehses JA, Lacraz G, Giroix M, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A 2009;106:13998–4003
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Sun H, Chen S. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol 2013;701:87--95
   Google Scholar
• Akash MSH, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 2012;101:1647–58
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010;12:263–71
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Salmani Z. Designing of a thermosensitive Chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J 2008;2:61–70
   Google Scholar
• Zhang Y, Roy S, Jones LS, et al. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1receptor antagonist in aqueous solution. J Pharm Sci 2004;93:3076–89
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm 1999;184:189–98
   PubMed Web of Science ®Google Scholar
• Kikwai L, Babu RJ, Prado R, et al. In vitro and in vivo evaluation of topical formulations of spantide II. AAPS PharmSciTech 2005;6:565–72
   PubMed Web of Science ®Google Scholar
• Chaibva FA, Walker RB. The comparison of in vitro release methods for the evaluation of oxytocin release from pluronic® f127 parenteral formulations. Dissolut Technol 2007;14:15–26
   Web of Science ®Google Scholar
• Hiwale P, Lampis S, Conti G, et al. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium. Biomacromolecules 2011;12:3186–93
   PubMed Web of Science ®Google Scholar
• Price NC. Conformational issues in the characterization of proteins. Biotechnol Appl Biochem 2000;31:29–40
   PubMed Web of Science ®Google Scholar
• Hyun H, Kim YH, Song IB, et al. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Biomarcomolecules 2007;78:1093–100
   Google Scholar
• Wannachaiyasit S, Phaechamud T. Development of chlorhexidine thermosensitive gels as a mouth antiseptic. J Metals Mater Miner 2010;20:165–8
   Google Scholar
• Nie S, Hsiao WW, Pan W, Yang Z. Thermosensitive pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomed 2011;6:151–61
   PubMed Web of Science ®Google Scholar
• Zhang L, Parsons DL, Navarre C, Kompella UB. Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 2002;85:73–81
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu WL, Wang JC, et al. Controlled delivery of recombinant hirudin based on thermosensitive pluronic® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization. J Control Release 2007;117:387–95
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Rasool F, et al. Alternate therapy of type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae). J Med Plants Res 2011;5:6885–9
   Web of Science ®Google Scholar
• Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 2012;114:525--31
   Google Scholar
• Remmele RL, Nightlinger NS, Srinivasan S, Gombotz WR. Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry. Pharm Res 1998;15:200–8
   PubMed Web of Science ®Google Scholar
• Kang F, Jiang G, Hinderliter A, et al. Lysozyme stability in primary emulsification for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients. Pharm Res 2002;19:629–33
   PubMed Web of Science ®Google Scholar
• Katakam M, Banga AK. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm Dev Technol 1997;2:143–9
   PubMedGoogle Scholar